BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Dr. Chris Centeno

Regenexx – Dr. Chris Centeno on the Orthopedic Applications of MSCs

November 9, 2021 By Cade Hildreth (CEO) 1 Comment

Regenexx, Interview with Dr. Chris Centeno - Using MSCs for Orthopedic Applications
Dr. Chris Centeno, CEO of Regenexx
Dr. Chris Centeno, Founder and CEO of Regenexx

Regenexx is a U.S. company specializing in orthopedic applications of stem cells that was founded by Dr. Chris Centeno. Dr. Centeno is an international expert in regenerative medicine and the clinical use of mesenchymal stem cells (MSCs) in orthopedic applications. His Regenexx clinic in Denver, Colorado, incorporates a variety of regenerative approaches, drawing patients from all over the U.S. who are seeking innovative, non-surgical treatments. [Read more…]

Filed Under: Interviews, MSCs Tagged With: Dr. Chris Centeno, interview, orthopedics, Regenexx

Is It the Era for Mesenchymal Stem Cells (MSCs)?

February 4, 2016 By Cade Hildreth (CEO) Leave a Comment

Is it the Era for Mesenchymal Stem Cells (MSCs)?

Wow! For the first time in history, the research of mesenchymal stem cells surpassed hematopoietic stem cell research within the scientific literature in 2015.

This is major news for the stem cell community, because it represents a shift in stem cell research activity.

Mesenchymal stem cells, of the five types analyzed, were the only type to also experience an increase in frequency of publication from 2014 to 2015 as well. Conversely, all four other types experienced decreases in publication during the aforementioned period.

Check out the metrics here: Mesenchymal Stem Cells Surpass Hematopoietic Stem Cells in the Scientific Literature for the 1st Time in History [Read more…]

Filed Under: HSCs, MSCs, Stem Cells Tagged With: Dr. Chris Centeno, hematopoietic stem cells, market research, mesenchymal stem cells

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.